Overview:
Dims-GM targets joint health by combining Diacerein, known for its IL-1 inhibitory properties, with Glucosamine, which enhances synovial fluid production. Studies show a 20% improvement in mobility over 12 weeks (Journal of Rheumatology, 2019).
Disease-Modifying Osteoarthritis Drug (DMOAD) + Joint Supplement
One tablet twice daily or as prescribed by the doctor
DIMS GM Tablets can be used in the treatment of the following conditions:
Osteoarthritis (OA)
Chronic joint pain and stiffness
Cartilage degeneration
Rheumatoid arthritis (RA) adjunct therapy
Degenerative joint diseases
Post-traumatic joint dysfunction
Synovial fluid deficiency disorders
Diacerein inhibits IL-1β and suppresses COX-2-driven inflammation, protecting cartilage. Glucosamine supports joint lubrication and repair through increased glycosaminoglycan production.